Authors:
Keler, T
Guyre, PM
Vitale, LA
Sundarapandiyan, K
van de Winkel, JGJ
Deo, YM
Graziano, RF
Citation: T. Keler et al., Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice, J IMMUNOL, 165(12), 2000, pp. 6738-6742
Authors:
Keler, T
Wallace, PK
Vitale, LA
Russoniello, C
Sundarapandiyan, K
Graziano, RF
Deo, YM
Citation: T. Keler et al., Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages, J IMMUNOL, 164(11), 2000, pp. 5746-5752
Authors:
Posey, JA
Raspet, R
Verma, U
Deo, YM
Keller, T
Marshall, JL
Hodgson, J
Mazumder, A
Hawkins, MJ
Citation: Ja. Posey et al., A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies, J IMMUNOTH, 22(4), 1999, pp. 371-379
Authors:
Watanabe, M
Wallace, PK
Keler, T
Deo, YM
Akewanlop, C
Hayes, DF
Citation: M. Watanabe et al., Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210, BREAST CANC, 53(3), 1999, pp. 199-207
Citation: Rk. Park et al., Role of Src in the modulation of multiple adaptor proteins in Fc alpha RI oxidant signaling, BLOOD, 94(6), 1999, pp. 2112-2120